Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Revenue

Verrica Pharmaceuticals had revenue of $3.44M in the quarter ending March 31, 2025, a decrease of -10.12%. This brings the company's revenue in the last twelve months to $7.18M, down -19.45% year-over-year. In the year 2024, Verrica Pharmaceuticals had annual revenue of $7.57M with 47.66% growth.

• Revenue (ttm): $7.18M
• Revenue Growth: -19.45%
• P/S Ratio: 4.40
• Revenue / Employee: $101,113
• Employees: 71
• Market Cap: 45.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.57M	2.44M	47.66%
Dec 31, 2023	5.12M	-3.91M	-43.27%
Dec 31, 2022	9.03M	-2.97M	-24.73%
Dec 31, 2021	12.00M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.